CN102018838A - Medicine for treating chronic rhinitis - Google Patents
Medicine for treating chronic rhinitis Download PDFInfo
- Publication number
- CN102018838A CN102018838A CN 201010550412 CN201010550412A CN102018838A CN 102018838 A CN102018838 A CN 102018838A CN 201010550412 CN201010550412 CN 201010550412 CN 201010550412 A CN201010550412 A CN 201010550412A CN 102018838 A CN102018838 A CN 102018838A
- Authority
- CN
- China
- Prior art keywords
- medicine
- chronic rhinitis
- radix
- herba
- rhinitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicine for treating chronic rhinitis, which takes biond magnolia flowerbud, asarum, adenophora stricta, forsythia, herba ephedra, ballonflowers, herba schizonepetae, radix paeoniae rubrathe, calamus, radix angelicae and myrobalan flesh as raw medicines. A preparation method of the medicine comprises the following steps of: cleaning the raw medicines by using clear water; airing; grinding into fine powder; and loading into capsules to prepare capsules. The medicine has the effects of diminishing inflammation and relieving pain, improving discomfort and enhancing the activity of cells of organisms, ideal rehabilitation effect and outstanding curative effect on treating the chronic rhinitis and can prevent the recrudescence of the chronic rhinitis and achieve the effective rate at 96.0 percent through clinical observation.
Description
Technical field
The present invention relates to a kind of medicine for the treatment of rhinitis, particularly relating to a kind of is the medicine of the treatment chronic rhinitis of crude drug preparation with Chinese medicine.
Background technology
Rhinitis is meant the inflammation of nasal membrane and submucous tissue, shows as hyperemia or edema, occurs symptoms such as nasal obstruction, snivel, rhinocnesmus, throat's discomfort, cough clinically.Modern life people's operating pressure is big, and the daily schedule is irregular, and living environment is seriously polluted, sucks pathogenic bacterium such as dust, antibacterial for a long time, just might destroy the normal function of nasal cavity, thereby it is diseases induced to cause antibacterial to grow at nasal cavity.According to statistics, in the crowd of modern metropolis life, the sickness rate of allergic rhinitis and chronic rhinitis is 15～25%, and is trend, the especially chronic rhinitis that rises year by year, has a strong impact on sleep, causes cisco unity malfunction.
For the treatment of rhinitis mainly be at the protopathy of rhinitis because of, different rhinitis medications are distinguished to some extent, allergic rhinitis needs antianaphylactic treatment, as hismanal, chlorphenamine etc.; General chronic rhinitis can be taken HUODAN WAN or various rhinitis tablets etc.; The atrophic rhinitis then needs to take vitamin medicaments.The obstinate refractory of chronic rhinitis wherein, protracted course of disease, general western medicine weak effect usually also can produce dependency and side effect, is difficult to reach the purpose of eradicating sufferer.
Summary of the invention
The purpose of this invention is to provide a kind of medicine for the treatment of chronic rhinitis, this medicine anti-inflammation and stopping pain improves discomfort, and the enhancing body cell viability has ideal rehabilitation effect.
The medicine that the present invention treats chronic rhinitis is that crude drug prepares by following parts by weight of traditional Chinese medicines:
Flos Magnoliae 8～12 Herba Asaris 1～5
Radix Adenophorae (Radix Glehniae) 10～15 Fructus Forsythiaes 10～15
Herba Ephedrae 1～5 Radix Platycodonis 4～8
Herba Schizonepetae 4～8 Radix Paeoniae Rubra 8～12
Rhizoma Acori Graminei 8～12 Radixs Angelicae Dahuricae 8～12
Terminalia flesh 4～8.
Said medicine can be made any dosage form on the pharmaceutics, as tablet, pill, powder, capsule etc., the preferred dosage form of the present invention is a capsule.
The concrete preparation method of medicine of the present invention is that above-mentioned each crude drug is cleaned with clear water, dries, and grinds to form fine powder, makes capsule in incapsulating.
Using method: oral, each 2, every day 3 times.
In the prescription of the present invention, Flos Magnoliae has the effect of dispersing wind and cold; The Herba Asari dispelling cold by warming the meridian, dissipating fluid-retention, wind-expelling pain-stopping; Radix Adenophorae (Radix Glehniae) clearing away heat and nourishing YIN, nourishing the lung to arrest cough; The Fructus Forsythiae heat-clearing and toxic substances removing, mass dissipating and swelling eliminating; Herba Ephedrae diaphoresis cold expelling, depressed lung-energy dispersing; The Radix Platycodonis lung qi dispersing eliminates the phlegm, the sore-throat relieving evacuation of pus; The Herba Schizonepetae diffusing wind that induces sweat, rash, the skin ulcer that disappears, hemostasis; The Radix Paeoniae Rubra clearing away heat and cooling blood, eliminating stasis to stop pain; The Rhizoma Acori Graminei eliminating phlegm of having one's ideas straightened out, vital energy regualting and blood circulation-promoting, diffusing wind dries; The Radix Angelicae Dahuricae is controlled nasal sinusitis, epistaxis; The terminalia flesh astringing intestine to stop diarrhea is astringed the lung, the pathogenic fire reducing sore-throat relieving.More than all medicines share, at the focus toxin expelling, recover nasal mucosa, percdation thoroughly sterilizes in mucomembranous cell, has anti-inflammation and stopping pain, improves uncomfortable, the effect of enhancing body cell viability and ideal rehabilitation effect, the treatment chronic rhinitis is evident in efficacy, can avoid the recurrence of chronic rhinitis.
For further investigating the clinical efficacy and the safety of medicine of the present invention, select 100 routine rhinitis patients that the curative effect of medicine of the present invention is carried out clinical observation.
100 routine cases are divided into two groups at random, every group 50 example, all the diagnosis basis and the typing of rhinitis is diagnosed as chronic rhinitis in the cases " the hals,Nasen und Ohrenheilkunde diagnostics " that all write according to Zheng Zhongli.
Therapeutic Method: matched group adopts sinusitis capsule every day 3 times, each 2; HUODAN WAN every day 3 times, each 6 grams.The treatment group adopts medicine of the present invention, and oral, every day 3 times, each 2,7 days is a course of treatment, observes 3 courses of treatment continuously.
Criterion of therapeutical effect is judged the regulation according to " hals,Nasen und Ohrenheilkunde diagnostics ", based on X line objective determination symptom, changes situation with reference to subjective symptom, divides recovery from illness, produce effects, effective, invalid level Four.Recovery from illness: subjective symptom, objective determination all recover normal; Produce effects: subjective symptom recovers normal, and objective determination partly recovers; Effectively: subjective symptom and objective determination all part recover; Invalid: subjective symptom and objective determination all do not have and are clearly better.
Two groups of case treatment back curative effect comparative results see Table 1.
Table 1 liang group case treatment back curative effect relatively
Clinical experiment is the result prove, drug effect of the present invention obviously is better than matched group, do not see any untoward reaction.
The specific embodiment
Embodiment 1
Get Flos Magnoliae 1Kg, Herba Asari 0.3Kg, Radix Adenophorae (Radix Glehniae) 1.5Kg, Fructus Forsythiae 1.5Kg, Herba Ephedrae 0.3Kg, Radix Platycodonis 0.6Kg, Herba Schizonepetae 0.6Kg, Radix Paeoniae Rubra 1Kg, Rhizoma Acori Graminei 1.2Kg, Radix Angelicae Dahuricae 1Kg, terminalia flesh 0.6Kg, above-mentioned each crude drug is cleaned with clear water, dry, grind to form fine powder, make capsule in incapsulating.
Embodiment 2
Get Flos Magnoliae 1.2Kg, Herba Asari 0.2Kg, Radix Adenophorae (Radix Glehniae) 1.2Kg, Fructus Forsythiae 1.2Kg, Herba Ephedrae 0.5Kg, Radix Platycodonis 0.8Kg, Herba Schizonepetae 0.6Kg, Radix Paeoniae Rubra 1.2Kg, Rhizoma Acori Graminei 1Kg, Radix Angelicae Dahuricae 0.8Kg, terminalia flesh 0.5Kg, above-mentioned each crude drug is cleaned with clear water, dry, grind to form fine powder, make capsule in incapsulating.
Claims (2)
1. medicine for the treatment of chronic rhinitis is that crude drug prepares by following parts by weight of traditional Chinese medicines:
Flos Magnoliae 8～12 Herba Asaris 1～5
Radix Adenophorae (Radix Glehniae) 10～15 Fructus Forsythiaes 10～15
Herba Ephedrae 1～5 Radix Platycodonis 4～8
Herba Schizonepetae 4～8 Radix Paeoniae Rubra 8～12
Rhizoma Acori Graminei 8～12 Radixs Angelicae Dahuricae 8～12
Terminalia flesh 4～8.
2. the medicine of treatment chronic rhinitis according to claim 1 is characterized in that described medicine is made capsule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201010550412 CN102018838A (en) | 2010-11-15 | 2010-11-15 | Medicine for treating chronic rhinitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201010550412 CN102018838A (en) | 2010-11-15 | 2010-11-15 | Medicine for treating chronic rhinitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102018838A true CN102018838A (en) | 2011-04-20 |
Family
ID=43860887
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201010550412 Pending CN102018838A (en) | 2010-11-15 | 2010-11-15 | Medicine for treating chronic rhinitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102018838A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103800579A (en) * | 2013-12-20 | 2014-05-21 | 施泽晶 | Traditional Chinese medicinal composition for treating chronic rhinitis and preparation method thereof |
| CN105343345A (en) * | 2015-11-30 | 2016-02-24 | 济南舜祥医药科技有限公司 | Capsule for treating rhinitis and preparation method |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1166388C (en) * | 2002-01-18 | 2004-09-15 | 陈炳南 | Medicine for treating nosal inflammation |
| CN101700282A (en) * | 2009-10-30 | 2010-05-05 | 于福源 | Traditional Chinese medicine for treating wind-cold rhinitis |
-
2010
- 2010-11-15 CN CN 201010550412 patent/CN102018838A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1166388C (en) * | 2002-01-18 | 2004-09-15 | 陈炳南 | Medicine for treating nosal inflammation |
| CN101700282A (en) * | 2009-10-30 | 2010-05-05 | 于福源 | Traditional Chinese medicine for treating wind-cold rhinitis |
Non-Patent Citations (1)
| Title |
|---|
| 《中医药研究》 20001031 李平等 慢性鼻炎中医药治疗进展 第57-58页 1-2 第16卷, 第5期 2 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103800579A (en) * | 2013-12-20 | 2014-05-21 | 施泽晶 | Traditional Chinese medicinal composition for treating chronic rhinitis and preparation method thereof |
| CN105343345A (en) * | 2015-11-30 | 2016-02-24 | 济南舜祥医药科技有限公司 | Capsule for treating rhinitis and preparation method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102145114B (en) | Novel traditional Chinese medicine for treating cold | |
| CN102846918A (en) | Drug for treating faucitis | |
| CN102038829A (en) | Medicament for treating gastritis and ulcers of stomachs and duodenums | |
| CN105381132A (en) | Drug for treating thyroid nodule | |
| CN102091268A (en) | Medicament for treating allergic rhinitis and preparation method thereof | |
| CN101816712B (en) | Chinese medicinal composition for treating trigeminal neuralgia | |
| CN101406633B (en) | Pellet for recuperation of neck and waist | |
| CN102018838A (en) | Medicine for treating chronic rhinitis | |
| CN102657785A (en) | Medicinal composition for treating gingivitis | |
| CN102018885A (en) | Chinese medicinal preparation for increasing immunity of organism | |
| CN102228582B (en) | Medicament for treating cough with asthma caused by chronic tracheitis and chronic tracheitis | |
| CN102205009B (en) | Traditional Chinese medicine for treating urinary tract stones | |
| CN103610831B (en) | A kind of Chinese medicine for the treatment of neck and shoulder pain | |
| CN103202927A (en) | Traditional Chinese medicinal preparation used for treating hemorrhoids | |
| CN102380063A (en) | Chinese medicament for treating diabetic foot | |
| CN101502597B (en) | Medicament for treating stomachache and preparation method thereof | |
| CN101961474B (en) | Chinese medicinal preparation for treating gastrointestinal diseases | |
| CN101596297B (en) | Tinea-curing pill | |
| CN101112602B (en) | Medicine for treating pharyngitis and method for preparing the same | |
| CN105362548A (en) | Traditional Chinese medicine for treating allergic asthma | |
| CN103041127A (en) | Traditional Chinese medicine composition for treating cough | |
| CN102380039A (en) | Oral traditional Chinese medicine prescription for treating upper gastrointestinal hemorrhage | |
| CN102114183A (en) | Medicament for treating hypertension | |
| CN102441088B (en) | Traditional Chinese medicinal liquor used for treating lumbar muscle fiber inflammation | |
| CN103463324B (en) | Medicinal composition for preventing or treating oral ulcer and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| AD01 | Patent right deemed abandoned |
Effective date of abandoning: 20110420 |
|
| C20 | Patent right or utility model deemed to be abandoned or is abandoned |